GAO report points to "gaps" in US FDA's device approval process
This article was originally published in Clinica
Executive Summary
The combined effect of the many "gaps" in the US Food and Drug Administration's oversight of the medtech sector may increase the risk of unsafe medical devices remaining on the market, the Government Accountability Office has stated in a new report.